IceCure Medical (NASDAQ:ICCM) & Auna (NYSE:AUNA) Financial Contrast

Auna (NYSE:AUNA) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability.

Earnings and Valuation

This table compares Auna and IceCure Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.17 billion	0.40	$29.39 million	$0.58	10.88
IceCure Medical	$3.29 million	15.26	-$15.32 million	($0.16)	-5.35

Auna has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Auna and IceCure Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Auna	5.49%	15.55%	3.62%
IceCure Medical	-317.62%	-136.96%	-71.46%

Institutional & Insider Ownership

0.6% of IceCure Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Auna has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Auna and IceCure Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	0	2	1	0	2.33
IceCure Medical	0	1	2	1	3.00

Auna currently has a consensus price target of $10.70, suggesting a potential upside of 69.57%. IceCure Medical has a consensus price target of $2.3850, suggesting a potential upside of 178.85%. Given IceCure Medical’s stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Auna.

Summary

Auna beats IceCure Medical on 8 of the 15 factors compared between the two stocks.

About Auna

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.